clarithromycin

clarithromycin is a lipid of Polyketides (PK) class. Clarithromycin is associated with abnormalities such as Helicobacter Pylori Infection, Infection, Coinfection, Gastritis and Peptic Ulcer. The involved functions are known as Point Mutation, Increased Sensitivy, Bacterial resistance, urease activity and Mutation. Clarithromycin often locates in Blood, Gastric mucosa, Biopsy sample, Respiratory System and Entire gastrointestinal tract. The associated genes with clarithromycin are Genes, rRNA, rRNA Operon, Genome, HM13 gene and GDF15 gene. The related lipids are 9,11-linoleic acid, Steroids, Lysophosphatidylcholines, Lipopolysaccharides and 4-hydroxycholesterol. The related experimental models are Mouse Model, Knock-out and Experimental Pneumococcal Meningitis.

Cross Reference

Introduction

To understand associated biological information of clarithromycin, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with clarithromycin?

clarithromycin is suspected in Infection, Helicobacter Pylori Infection, Pneumonia, Respiratory Tract Infections, PARKINSON DISEASE, LATE-ONSET, Community acquired pneumonia and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with clarithromycin

MeSH term MeSH ID Detail
Hemolysis D006461 131 associated lipids
Tuberculosis D014376 20 associated lipids
Stomach Ulcer D013276 75 associated lipids
Nocardia Infections D009617 6 associated lipids
Diarrhea D003967 32 associated lipids
Hearing Loss, Sensorineural D006319 8 associated lipids
Otitis Media D010033 12 associated lipids
Carcinoma, Basal Cell D002280 6 associated lipids
Arrhythmias, Cardiac D001145 42 associated lipids
Adenocarcinoma D000230 166 associated lipids
Per page 10 20 50 100 | Total 242

PubChem Associated disorders and diseases

What pathways are associated with clarithromycin

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with clarithromycin?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with clarithromycin?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with clarithromycin?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with clarithromycin?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with clarithromycin?

Mouse Model

Mouse Model are used in the study 'Inflammation provoked by Mycoplasma pneumoniae extract: implications for combination treatment with clarithromycin and dexamethasone.' (Hirao S et al., 2011), Mouse Model are used in the study 'Tolerance and pharmacokinetic interactions of rifabutin and clarithromycin in human immunodeficiency virus-infected volunteers.' (Hafner R et al., 1998), Mouse Model are used in the study 'Clarithromycin attenuates mastectomy-induced acute inflammatory response.' (Chow LW et al., 2000) and Mouse Model are used in the study 'In vitro and in vivo influence of adjunct clarithromycin on the treatment of mucoid Pseudomonas aeruginosa.' (Bui KQ et al., 2000).

Knock-out

Knock-out are used in the study 'Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38).' (Nash KA, 2003).

Experimental Pneumococcal Meningitis

Experimental Pneumococcal Meningitis are used in the study 'Failure of treatment for chronic Mycobacterium abscessus meningitis despite adequate clarithromycin levels in cerebrospinal fluid.' (Maniu CV et al., 2001).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with clarithromycin

Download all related citations
Per page 10 20 50 100 | Total 7636
Authors Title Published Journal PubMed Link
Gu LK et al. [Effect of selenium-enriched garlic on chronic gastritis of the glandular stomach of Mongolian gerbils induced by H. pylori]. 2007 Zhonghua Yu Fang Yi Xue Za Zhi pmid:17767872
Lo WC et al. Clarithromycin in the combination therapy for the eradication of Helicobacter pylori in peptic ulcer disease. 1997 Zhonghua Yi Xue Za Zhi (Taipei) pmid:9198292
Huang WH et al. New one-week, low-dose triple therapy for the treatment of duodenal ulcer with Helicobacter pylori infection. 1998 Zhonghua Yi Xue Za Zhi (Taipei) pmid:9745160
Cheng H et al. [Influence of resistance of Helicobacter pylori to antibiotics on the Helicobacter pylori eradication regimens]. 2006 Zhonghua Yi Xue Za Zhi pmid:17199976
Cheng H and Hu FL [The epidemiology of Helicobacter pylori resistance to antibiotics in Beijing]. 2005 Zhonghua Yi Xue Za Zhi pmid:16324315
Zheng XL and Xu L [Efficacy of second-line treatment based on moxifloxacin triple therapy for Helicobacter pylori infection]. 2010 Zhonghua Yi Xue Za Zhi pmid:20356487
Cheng H et al. [Levofloxacin-based triple therapy for first-line Helicobacter pylori eradication treatment: a multi-central, randomized, controlled clinical study]. 2010 Zhonghua Yi Xue Za Zhi pmid:20356486
Hu FL [A multicenter study of Chinese patent medicine wenweishu/yangweishu in the treatment of Helicobacter pylori positive patients with chronic gastritis and peptic ulcer]. 2010 Zhonghua Yi Xue Za Zhi pmid:20356485
Chai D et al. [Effect of macrolides on biofilm of mucoid Pseudomonas aeruginosa]. 2001 Zhonghua Yi Xue Za Zhi pmid:11702671
Meng X et al. [Antibiotic resistance of Helicobacter pylori clinical isolates in Hebei Province]. 2016 Zhonghua Yi Xue Za Zhi pmid:26879786
Hu FL et al. [Jinghuaweikang capsules combined with triple therapy in the treatment of Helicobacter pylori associated gastritis and duodenal ulcer and analysis of antibiotic resistance: a multicenter, randomized, controlled, clinical study]. 2012 Zhonghua Yi Xue Za Zhi pmid:22781295
[Effects of different triple therapies on duodenal ulcer-associated Helicobacter pylori infection and a one-year follow-up study]. 2004 Zhonghua Yi Xue Za Zhi pmid:15387976
Zheng XL et al. [Genotypic homogeneity and susceptibility to clarithromycin for clarithromycin-resistant Helicobacter pylori strains]. 2009 Zhonghua Yi Xue Za Zhi pmid:19953885
Zou J et al. [Laboratory and clinical study of levofloxacin against Helicobacter pylori]. 2003 Zhonghua Yi Xue Za Zhi pmid:14642083
Zheng X et al. [The prevalence and mechanism of Helicobacter pylori resistance to clarithromycin in Beijing]. 2001 Zhonghua Yi Xue Za Zhi pmid:11930609
Zheng X et al. [The resistance of Helicobacter pylori toward metronidazole and clarithromycin]. 2001 Zhonghua Yi Xue Za Zhi pmid:11769712
Chen B et al. [Pulmonary disease caused by nontuberculous mycobacteria after allogeneic hematopoietic stem cell transplantation--a case report and literature review]. 2004 Zhonghua Xue Ye Xue Za Zhi pmid:15555262
He XX et al. [Effect of CYP2C19 genetic polymorphism on treatment efficacy of Helicobacter pylori infection with rabeprazole-based triple therapy in Chinese]. 2004 Zhonghua Nei Ke Za Zhi pmid:14990013
Wang LJ et al. [The effects of Helicobacter pylori infection on hyperammonaemia and hepatic encephalopathy in cirrhotic patients]. 2006 Zhonghua Nei Ke Za Zhi pmid:17074151
Zhang L et al. [Minocycline quadruple versus tailored therapy in retreatment of Helicobacter pylori infection]. 2015 Zhonghua Nei Ke Za Zhi pmid:26887366
Chen S et al. [Omeprazole, clarithromycin and amoxicillin therapy for Helicobacter pylori infection]. 1996 Zhonghua Nei Ke Za Zhi pmid:9592303
Liu W et al. [Clarithromycin combined short-term triple therapies for eradication of Helicobacter pylori infection]. 1996 Zhonghua Nei Ke Za Zhi pmid:9592304
Gui J et al. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing]. 2013 Zhonghua Jie He He Hu Xi Za Zhi pmid:24252731
Lu Y et al. [A study on the activity of clofazimine with antituberculous drugs against Mycobacterium tuberculosis]. 2010 Zhonghua Jie He He Hu Xi Za Zhi pmid:21092635
Nie W et al. [The analysis of species identification and susceptibility testing of Mycobacterium abscessus]. 2014 Zhonghua Jie He He Hu Xi Za Zhi pmid:25262693
Duan HF et al. [Susceptibility test of the Mycobacterium avium complex to sixteen anti-infective agents]. 2010 Zhonghua Jie He He Hu Xi Za Zhi pmid:20646615
Zhao C et al. [Resistance surveillance of major pathogens for adult community-acquired respiratory tract infections in China: a multicenter study 2012]. 2015 Zhonghua Jie He He Hu Xi Za Zhi pmid:25791651
Chen PR and Tan SY [The treatment outcomes of 21 cases of rapidly growing mycobacteria related pulmonary disease]. 2013 Zhonghua Jie He He Hu Xi Za Zhi pmid:23856140
Fu Y et al. [The effect of interventional therapy in multimodality treatment on multi-drug resistant pulmonary tuberculosis]. 2008 Zhonghua Jie He He Hu Xi Za Zhi pmid:18683778
Weng KR et al. [Treatment and a follow-up study on wound infection by Mycobacterium chelonae: report of 168 cases]. 2004 Zhonghua Jie He He Hu Xi Za Zhi pmid:15196343
Gui J et al. [Subspecies identification for Mycobacterium abscessus group]. 2014 Zhonghua Jie He He Hu Xi Za Zhi pmid:25262692
Sun H et al. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from class B hospitals in China during 2013 and 2014]. 2016 Zhonghua Jie He He Hu Xi Za Zhi pmid:26792053
Wang H et al. [Antimicrobial susceptibility of community-acquired respiratory tract pathogens isolated from adults in China during 2009 and 2010]. 2012 Zhonghua Jie He He Hu Xi Za Zhi pmid:22455967
Yan WH et al. [Rapid detection of clarithromycin resistant Helicobacter pylori from children's gastric biopsy specimens by polymerase chain reaction-restriction fragment length polymorphism]. 2009 Zhonghua Er Ke Za Zhi pmid:20078998
Yan WH et al. [Preliminary study on in-vitro induction of antibiotic resistance in Helicobacter pylori strains isolated from children]. 2007 Zhonghua Er Ke Za Zhi pmid:18021568
Hua CZ et al. [Serotypes and antibiotics-resistance patterns of 247 strains of Haemophilus Influenzae isolated from children in Hangzhou]. 2004 Zhonghua Er Ke Za Zhi pmid:15631716
Chen J et al. [Prevalence of Helicobacter pylori resistant to clarithromycin, amoxicillin and metronidazole in children]. 2004 Zhonghua Er Ke Za Zhi pmid:16221349
Chen XX et al. [Long-term therapeutic effect of triple therapy consisted of omeperazole, clarithromycin and amoxycillin in children with Helicobacter pylori infection and approach to re-treatment after failure of the treatment]. 2004 Zhonghua Er Ke Za Zhi pmid:15265423
Huang J et al. [A 10-day sequential therapy for eradication of Helicobacter pylori infection in children]. 2012 Zhonghua Er Ke Za Zhi pmid:23158730
Chen J et al. [Prevalence and mechanism of Helicobacter pylori resistance to clarithromycin in children]. 2004 Zhonghua Er Ke Za Zhi pmid:15631715
Yang H et al. [Macrolide-resistant Streptococcus pneumoniae in the pediatric population in Beijing]. 2004 Zhonghua Er Ke Za Zhi pmid:15733368
Wang Y et al. [Analysis of the infection status and the drug resistance of mycoplasma and chlamydiae in genitourinary tracts of children with suspected nongonococcal urethritis]. 2009 Zhonghua Er Ke Za Zhi pmid:19573386
Luo Q et al. [Clinical effect of clarithromycin therapy in patients with chronic rhinosinusitis]. 2014 Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi pmid:24742507
Guo SB et al. [Preparation and identification of the oligonucleotide chip for detecting the virulence-associated genotypes and drug resistance of Helicobacter pylori]. 2007 Zhongguo Yi Xue Ke Xue Yuan Xue Bao pmid:17380677
Yang CS et al. [Study of correlation between Helicobacter pylori infection and hyperammonemia and hepatic encephalopathy in cirrhotic patients]. 2007 Zhongguo Wei Zhong Bing Ji Jiu Yi Xue pmid:17631712
Zhao HM et al. [Clinical effect of triple therapy combined with Saccharomyces boulardii in the treatment of Helicobacter pylori infection in children]. 2014 Zhongguo Dang Dai Er Ke Za Zhi pmid:24661511
Huang LP et al. [Antimicrobial resistance of 36 strains of Helicobacter pylori in adolescents]. 2009 Zhongguo Dang Dai Er Ke Za Zhi pmid:19292962
Xiang L et al. [Different courses of esomeprazole-based triple therapy for Helicobactor pylori infection in children]. 2007 Zhongguo Dang Dai Er Ke Za Zhi pmid:17582255
Wang F et al. [Five-day rabeprazole-based triple therapy for helicobacter pylori infection]. 2004 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:16137055
Wang F et al. [Antibiotic resistance of Helicobacter pylori]. 2007 Zhong Nan Da Xue Xue Bao Yi Xue Ban pmid:17611323